Peer-influenced content. Sources you trust. No registration required. This is HCN.

News MedicalHigh Intake of Saturated Fat Can Promote Favorable Changes in Cardiovascular Risk Markers

⚠️ Outdated Clinical Content / Potential for Misinterpretation

CARBFUNC randomized 193 adults with obesity to three dietary patterns, with follow-up extending to two years. This secondary analysis compared a very-low-carbohydrate, high-saturated-fat diet with two higher-carbohydrate, lower-fat diets differing in carbohydrate refinement. The high-fat group showed lower triglycerides and higher HDL-C alongside increased LDL-C, without an appreciable apoB increase. These findings describe lipid responses to a combined dietary intervention, not the isolated effect of saturated fat or demonstrated reductions in cardiovascular events.


Clinical Considerations

  • LDL-C increased 5–10%, primarily through larger particles. Particle size does not establish that the increase was clinically inconsequential.
  • Triglycerides fell 20–35% and HDL-C rose 5–18% in the high-fat group; these biomarker changes do not establish cardiovascular benefit.
  • ApoB did not change appreciably or differ appreciably between diets. The report provides no confidence intervals establishing equivalence.
  • Coronary calcium progression did not clearly differ between groups at 12 months; this does not establish equivalent long-term atherosclerotic risk.
  • Carbohydrate restriction accompanied higher saturated-fat intake. Shared sugar reduction and vegetable recommendations further limit attribution to saturated fat alone.
  • The report does not detail attrition, achieved dietary adherence, medication changes, or endpoint-specific sample sizes, limiting assessment of durability and precision.

Practice Applications

  • Interpret LDL-C, apoB, triglycerides, and HDL-C together without assuming favorable changes in some markers cancel potential risk from others.
  • Recognize that findings in adults with obesity may not generalize to other populations or establish safety for higher-risk patients.
  • Avoid presenting this analysis as grounds to increase saturated-fat intake or change lipid treatment; it does not establish guideline-supported practice change.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form